Residence​/Ladder Faculty - Gladstone-UCSF Institute of Genomic Immunology

Position Description Gladstone-UCSF Institute of Genomic Immunology Description

The Gladstone-UCSF Institute of Genomic Immunology seeks to recruit faculty at the Assistant, Associate or Full Professor level. Candidates must have a strong background in immunology, genomics, genetics, genome engineering, synthetic biology and/or clinical immunotherapy, and significant achievements and meaningful promise in their field. We invite applications from scientists with Ph.D., M.D. (or equivalent degree), or M.D/Ph.D. degrees (or equivalent degrees) who are establishing or have established a research program in genomic immunology research.

Relevant areas of research include, but are not limited to:

• Functional genomic studies in cells of the immune system
• Genome engineering to enhance adoptive cellular therapies
• Genetic/genomic studies of human diseases of the immune system
• Protein design and engineering in the context of the immune system and immunotherapies
• Systems immunology and immunotherapy
• Disease expertise in autoimmunity, inflammation or other conditions that may benefit from future immunotherapies

Investigators will be expected to develop extramurally sponsored research programs and educate, mentor, and develop graduate and medical students. Successful candidate(s) will be appointed to an appropriate UCSF department as an Assistant, Associate or Full Professor (in residence or ladder-rank), and will be assigned dedicated research space on the UCSF Parnassus Campus and/or at Gladstone Institutes at Mission Bay.

To harness the immense potential offered by immunotherapies, the Gladstone-UCSF Institute of Genomic Immunology combines emerging biomedical technologies at the intersection of human immunology, genomics, CRISPR genome engineering, computational biology, and synthetic biology.

The institute’s scientists deepen knowledge of how DNA sequences control cell functions in the human immune system. Their discoveries will enable the next generation of immunotherapies for cancer, autoimmune diseases, infectious diseases, inflammation and beyond.

This institute is the result of a close partnership between Gladstone Institutes and the University of California, San Francisco (UCSF). With wet and dry lab space to be housed (starting in 2027) in a new building on the Mission Bay campus, it creates a unified community across the two campuses and combines UCSF’s world-class immunology and planned cell therapy efforts with Gladstone’s expertise in the host-pathogen interface, iPS cells, computational biology, and CRISPR gene editing technologies.

Gladstone Institutes is an independent, not-for-profit research organization affiliated with the University of California San Francisco (UCSF) and a renowned center of excellence focused on applying basic science to disease. Our science contributes to the health and wellbeing of all people through research, education, and outreach in the areas of cardiovascular disease, neurological disease, virology, immunology, and data science. Gladstone has a vibrant group of labs and core facilities focused on emerging and highly innovative technologies for biomedical research, including stem cells, imaging, single-cell genomics, mass spectrometry, and genome editing.

Bioinformatics and biostatistics play a central role in this collaborative team.

UC San Francisco is the leading university dedicated to advancing health worldwide through preeminent biomedical research, graduate-level education in the life sciences and health professions, and excellence in patient care. Within our overarching advancing health worldwide mission, UCSF is devoted at every level to serving the public.

• Ph.D., M.D. (or equivalent degree), or M.D/Ph.D. degrees (or equivalent degrees)
• Candidates must be establishing, or have an established research program in genomic immunology or immunotherapy research. Relevant areas of research include, but are not limited to:
• Functional genomic studies in cells of the immune system
• Genome engineering to enhance adoptive cellular therapies
• Genetic/genomic studies of…